REFERENCES

1. Walker I, Chappell LC, Williamson C. Abnormal liver function tests in pregnancy. BMJ 2013;347:f6055.

2. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG. Prospective study of liver dysfunction in pregnancy in Southwest Wales.

3. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal compli­cation rates. Hepatology 2004;40:467-74.

4. Ovadia C, Sklavounos A, Geenes V, et al. Adverse perinatal out­comes of intrahepatic cholestasis of pregnancy and association with biochemical markers: results of aggregate and independent patient data meta-analyses. Lancet 2019 Feb 14;393:899-909. pii: S0140-6736(18)31877-4. doi: 10.1016∕S0140-6736(18)31877-4. PMID: 30773280.

5. Chappell LC, Gurung V, Seed PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012;344:e3799.

6. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial com­paring dexamethasone and ursodeoxycholic acid. Hepatology 2005;42:1399-405.

7. Bacq Y, Sentilhes L, Reyes HB, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-ana- lysis. Gastroenterology 2012;143:1492-501.

8. Chappell LC, Bell J, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C*, Thornton JG*. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet May 2019; doi: 10.1016∕S0140-6736(19)31270-X. PMID: 31378395.

9. Herraez E, Lozano E, Poli E, et al. Role of macrophages in bile acid-induced inflammatory response of fetal lung during ma­ternal cholestasis.

10. Zhang Y, Li F, Wang Y, et al. Maternal bile acid transporter defi­ciency promotes neonatal demise. Nat Commun 2015;6:e8186.

11. Marschall HU, Wikstrom Shemer E, Ludvigsson JF, Stephansson

O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-ba sed cohort study. Hepatology 2013;58:1385-391.

12. Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst

P, UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008;57:951-56.

13. Chng CL, Kingham JG, Morgan M. Acute fatty liver in pregnancy in the UK. Gut 2009;58:467-68.

14. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999;340:1723-31.

15. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107:115-20.

16. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus in­fection. J Hepatol 2012;57:167-85.

17. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepatol 2003;10:61-69.

18. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS. Hepatitis E in pregnancy. Int J Gynecol Obstet 2004;85:240-44.

19. Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on pre­scribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and cortico­steroids. Rheumatology 2016;299:1-5.

20. Rautou PE, Angermayr B, Garcia-Pagan JC, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: ma­ternal and fetal outcomes. J Hepatol 2009;51:47-54.

21. Poupon R, Chretien Y, Chazouilleres O, Poupon RE. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cir­rhosis.

22. Janczewska I, Olsson R, Hultcrantz R, Broome U. Pregnancy in patients with primary sclerosing cholangitis. Liver 1996; 16: 326-30.

23. Lu EJ, Curet MJ, El-Sayed YY, Kirkwood K. Medical versus sur­gical management of biliary tract disease in pregnancy. Am J Surg 2004;188:755-59.

24. Westbrook RH, Yeoman AD, Agarwal K, et al. Outcomes of preg­nancy following liver transplantation: The King’s College Hospital experience. Liver Transpl 2015;21:1153-59.

25. Blazer S. Maternal hypothyroidism may affect fetal growth and neonatal thyroid function. Obstet Gynecol 2003;102:232-41.

26. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid defi­ciency during pregnancy and subsequent neuropsychological de­velopment of the child. N Engl J Med 1999;341:549-55.

27. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thy­roxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999;50:149-55.

28. Wiles KS, Jarvis S, Nelson-Piercy C. Are we overtreating subclin- ical hypothyroidism in pregnancy? BMJ 2015;12:h4726.

29. Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thy­roid screening and childhood cognitive function. N Engl J Med 2012;366:493-501.

30. Maraka S, O’Keeffe DT, Montori VM. Subclinical hypothyroidism during pregnancy—should you expect this when you are expecting? A teachable moment. JAMA Intern Med 2015;175:1088-89.

31. Kothari A, Girling J. Hypothyroidism in pregnancy: pre-preg- nancy thyroid status influences gestational thyroxine require­ments. BJOG 2008;115:1704-708.

32. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol 2003; 59:282-88.

33. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.

34. Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception. N Engl J Med. 2019 Apr 4;380(14):1316-1325. doi: 10.1056/ NEJMoa1812537. PMID: 30907987.

35. Yoshihara A, Noh JY, Yamaguchi T, et al. Treatment of Graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012;97:2396-403.

36. Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. JCEM 2013;98:4373-81.

37. Bahn RS, Burch HS, Cooper DS, et al. The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009;19:673-74.

38. Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK. Cushing’s syn­drome during pregnancy: personal experience and review of the literature. JCEM 2005;90:3077-83.

39. Vilar L, Conceiqao Freitas M, LimaII LHC, LyraII R, Kater CE. Cushing’s syndrome in pregnancy: an overview. Arq Bras Endocrinol Metabol 2007;51:1293-302.

40. Lim WH, Torpy DJ, Jeffries WS. The medical management of Cushing’s syndrome during pregnancy. Eur J Obstet Gynaecol Reprod Biol 2013;168:1-6.

41. Quartermaine G, Lambert K, Rees K, et al. Women with hormone- secreting adrenal tumours in pregnancy have severe hyperten­sion and increased rates of adverse pregnancy outcome. BJOG 2017;DOI: 10.1111/1471-0528.14918. PMID: 28872770.

42. Biggar MA, Lennard TW Systematic review of phaeochromo- cytoma in pregnancy. Br J Surg 2013;100:182-90.

43. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: re­commendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 2007;3:92-102.

44. Lan BY, Taskin HE, Aksoy E, et al. Factors affecting the surgical approach and timing of bilateral adrenalectomy.

45. Monticone S, Auchus RJ, Rainey WE. Adrenal disorders in preg­nancy. Nat Rev Endocrinol 2012;8:668-78.

46. Molitch ME. Endocrinology in pregnancy: management of the preg­nant patient with a prolactinoma. EurJEndocrinol 2015;172:R205-13.

47. Lebbe M, Hubinont C, Bernard P, Maiter D. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyper- prolactinaemic women. Clin Endocrinol (Oxf) 2010;73:236-42.

48. Lambert K, Rees K, Seed P, et al. Pituitary tumours in pregnancy: a 3 year prospective UK national cohort study. Obstet Gynecol. 2017 Jan; 129(1):185-94. PMID: 27926659. DOI: 10.1097/ A0G.0000000000001747.

49. Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 2006;65:265-73.

50. Melmed SF, Casanueva F, Hoffman AR, et al. Diagnosis and treat­ment of hyperprolactinemia: an Endocrine Society clinical prac­tice guideline. J Clin Endocrinol Metab 2011;96:273-78.

51. Raymond JP, Goldstein E, Konopka P, Leleu MF, Merceron RE, Loria Y. Follow-up of children born of bromocriptine-t reated mothers. Horm Res 1985;22:239-46.

52. Robert E, Musatti L, Piscitelli G, Ferrari CI. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 1996;10:333-37.

53. Webster J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 1996;14:228-38.

54. De Heide JLM, van Tol KM, Doorenbos B. Pituitary apoplexy pre­senting during pregnancy. Neth JMed 2004;62:393-96.

55. Gutenberg A, Larsen J, Lupic I, Rohdea V, Catureglid P. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR 2009;30:1766-72.

56. Schnatz PF, Thaxton S. Parathyroidectomy in the third trimester of pregnancy. Obstet Gynecol Surv 2005;60:672-82.

57. Norman J, Politz D, Politz L. Hyperparathyroidism during preg­nancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf) 2009;71:104-109.

58. Casey BM, Leveno KJ. Thyroid disease in pregnancy. Obstet Gynecol 2006;108:1283-89.

59. Chan BY, Swaminathan R. Serum thyrotrophin concentra­tion measured by sensitive assays in normal pregnancy. BJOG 1988;95:1332-36.

60. Parker JH. Amerlex free triiodothyronine and free thyroxine levels in normal pregnancy. BJOG 1985;92:1234-38.

61. Soldin OP, Soldin D, Sastoque M. Gestation-specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Ther Drug Monit 2007;29:553-59.